期刊文献+

重组人血管内皮抑制素促进肺癌细胞共培养体系中血管内皮细胞的凋亡机制研究

Mechanism of Recombinant Human Endostatin on Promoting Apoptosis of Vascular Endothelial Cell in Non-samll Lung Cancer Cell Co-culture System
下载PDF
导出
摘要 目的研究重组人血管内皮抑制素注射液(Endostar,恩度)促进与肺癌细胞A549共培养体系中的人脐静脉内皮细胞(HUVEC)凋亡及其机制研究。方法通过四甲基偶氮唑蓝(MTT),评价恩度对HUVECs增殖抑制作用;以流式细胞术Annexin V-FITC测定细胞凋亡率;以免疫细胞化学法测定恩度对抑凋亡蛋白Bcl-2和促凋亡蛋白Bax的影响;以Western blotting检测恩度对Bcl-2和Bax蛋白表达的影响。结果恩度能显著抑制肺癌细胞A549/HUVEC共培养体系中HUVEC的增殖;促进HUVECs凋亡;Annexin V-FITC测定显示10、20、40、80、100μg/mL浓度的恩度的凋亡率分别为(5.29±1.21)%、(8.33±0.62)%、(14.81±0.77)%、(21.87±0.96)%、(26.15±1.06)%;免疫细胞化学法和Western blotting检测显示恩度显著下调Bcl-2和上调Bax蛋白的表达。结论结果表明恩度能通过调控Bcl-2家族蛋白促进肺癌细胞与HUVEC共培养中血管内皮细胞的凋亡。 Objective To study the mechanism of recombinant human endostatin injection(Endostar) on promoting the apoptosis of human umbilical vein endothelial cells(HUVEC) in non–small lung cancer cell line A549 co-culture system.Methods Tetrazolium blue(MTT) and was used for the evaluation on proliferation inhibition of Endostar in HUVECs;Annexin V-FITC flow cytometry was used to determine the apoptosis rate;the effect of Endostar on Bcl-2 and Bax proteins expression in HUVEC by immunocytochemistry and Western blotting.Results Endostar can significantly inhibit HUVEC proliferation and significantly promote its apoptosis in A549 co-cultured system;the apoptosis rate were 5.29±1.21%(10μg/mL),8.33±0.62%(20μg/mL),14.81±0.77%(40μg/ mL),21.87±0.96%(80μg/mL),26.15±1.06%(100μg/mL) by Annexin V-FITC tests;Endostar significantly down-regulated Bcl-2 and up-regulated Bax proteins expression.Conclusions Endostar can promote HUVEC apoptosis in non-small lung cancer cell co-cultured system via regulating Bcl-2 family proteins expression.
作者 陈小平 张茜
出处 《中国医药指南》 2012年第30期399-401,共3页 Guide of China Medicine
关键词 恩度 血管内皮细胞 凋亡 Bcl-2 Endostar Vascular endothelial cells Apoptosis Bcl-2
  • 相关文献

参考文献6

二级参考文献23

  • 1陈彦凡,陈少贤,范小芳,黄卡特,王良兴.不同间期慢性低O_2高CO_2肺动脉高压大鼠血管内皮生长因子的变化[J].中国病理生理杂志,2005,21(3):502-505. 被引量:3
  • 2王金万,孙燕,刘永煜,于起涛,张沂平,李凯,朱允中,周清华,侯梅,管忠震,李维廉,庄武,王东林,梁后杰,秦凤展,卢辉山,刘晓晴,孙红,张燕军,王杰军,罗素霞,杨瑞合,涂远荣,王秀问,宋恕平,周静敏,游丽芬,王竞,姚晨.重组人血管内皮抑素联合NP方案治疗晚期NSCLC随机、双盲、对照、多中心Ⅲ期临床研究[J].中国肺癌杂志,2005,8(4):283-290. 被引量:625
  • 3李忠义 陈林生 等.人血管内皮抑制素的基因克隆、表达及其抗肿瘤效应的研究[A]..中华医学会辽宁分会第六次微生物免疫学术会议文汇编[C].,2000.2-3.
  • 4O'Reilly MS,Boehm T,Shing Y,et al.Endostatin:An endogenous inhibitor of angiogenesis and tumor growth[J].Cell,1997,99(2):277-295.
  • 5Digtyar AV,Pozdnyakova NV,Feldman NB,et al.Endostatin:current concepts about its biological role and mechanisms of action[J].Biochemistry(Mosc),2007,72(3):235-246.
  • 6Nikolai NK,Jianqing Y,Edwardine L,et al.Tumor-endothelium interactions in co-culture:coordinated changes of gene expression profiles and phenotypic properties of endothelial cells[J].J Cell Sci,2003,116(6):1013-1022.
  • 7Darland DC,D'Amore PA.Blood vessel maturation:vascular development comes of age[J].J Clin Invest,1999,103:157-158.
  • 8Carmeliet P,Jain RK.Angiogenesis in cancer and other diseases[J].Nature,2000,407(6801):249-257.
  • 9Arkudas A,Tjiawi J,Bleizifer O,et al.Fibrin gel-immobilized VEGF and bFGF efficiently stimulate angiogenesis in the AV loop model[J].Mol Med,2007,13(9-10):480-487.
  • 10Abdollahi A,Hahnfeldt P,Maercker C,et al.Endostatin's antiangiogenic signaling network[J].Mol Cell,2004,13(5):649-663.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部